<DOC>
	<DOCNO>NCT00783835</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety assess impact treatment quality life long-acting methylphenidate adult participant Attention Deficit Hyperactivity Disorder ( ADHD ) . ADHD clinical condition begin childhood characterize inadequate level attention , hyperactivity impulsiveness .</brief_summary>
	<brief_title>Study Evaluate Efficacy Quality Life Long-Acting Methylphenidate Adults With Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) , multi-center ( one hospital medical school team work medical research study ) , single arm study multiple dose long-acting methylphenidate participant ADHD . The study consist 2 phase ; screen phase treatment phase . The duration participation study individual participant 12 week . Participants give 18 milligram ( mg ) long-acting methylphenidate daily morning titrate ( slow increase drug dosage guide participant 's response ) 36 mg per day ( mg/day ) Day 8 . Depending response , tolerability clinician 's judgment , dose could escalate next dose level 54 mg/day Day 28 maximum 72 mg/day Day 56 , participant achieve optimal dose . Participant 's safety monitor throughout study .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Inclusion Criteria Diagnosis Attention Deficient Hyperactivity Disorder ( ADHD ) accord Diagnostic Statistical Manual Mental Diseases , Fourth Edition ( DSMIV ) , obtain via interview adapt version KiddieSchedule Affective Disorders SchizophreniaEpidemiologic Version ( KSADS E ) module ADHD Described chronic course ADHD symptomatology childhood adulthood , symptoms present age 7 year , continue meet DSMIV criterion time assessment . ADHD diagnose symptom well account another psychiatric disorder [ e.g . mood disorder ( especially bipolar disorder ) , anxiety disorder , psychotic disorder , personality disorder ] Clinical Global ImpressionSeverity ( CGISeverity ) baseline score great equal ( &gt; = ) 4 ( least moderate severity ) Female participant must postmenopausal ( time life woman stop menstrual period ) least 1year , surgically sterile , practice effective method birth control ( e.g. , prescription oral contraceptive [ compound , usually hormonal , take orally order block ovulation prevent occurrence pregnancy ] , contraceptive injection [ chemical substance prevent reduce probability pregnancy ] , intrauterine device [ contraceptive device place high uterine fundus ] , doublebarrier method , contraceptive patch , male partner sterilization ) entry throughout study ; negative urine pregnancy test baseline Participant agree take supplied study drug treatment ADHD study Exclusion Criteria Participant allergy hypersensitivity methylphenidate Participants nonresponder methylphenidate adequate dos ( i.e. , 0.8 1.0 milligram per kilogram [ mg/kg ] ) Participant treat methylphenidate amphetamine contain medication within 4 week screen visit Participant Hamilton 's Depression Scale , suicide item high 2 Participant psychiatric condition include follow , limited : acute mood disorder ( disorder disturbance mood main feature ) , schizophrenia ( mixed psychiatric disorder relate complex psychotic state feature schizophrenia mood disorder bipolar disorder ) , bipolar disorder I ( disorder mark severe mood swing ( manic major depressive episode ) tendency remission [ medical problem get good go away least ] recurrence [ happen ] ) , obsessive compulsive disorder ( OCD ) ( anxiety disorder characterize recurrent , persistent obsession compulsion , antisocial personality disorder ( personality disorder whose essential feature pervasive pattern disregard , violation , right others begin childhood early adolescence continue adulthood )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Methylphenidate</keyword>
	<keyword>Concerta</keyword>
	<keyword>CONQoL</keyword>
</DOC>